Perioperative changes of serum albumin are a predictor of postoperative pulmonary complications in lung cancer patients: a retrospective cohort study.

Pengfei Li,Jue Li,Yutian Lai,Yan Wang,Xin Wang,Jianhua Su,Guowei Che
DOI: https://doi.org/10.21037/jtd.2018.09.113
2018-01-01
Journal of Thoracic Disease
Abstract:Background: A decrease in serum albumin is commonly observed after lung cancer surgery, however, whether it is associated with postoperative outcomes is unknown. The objective of this study was to evaluate whether the reduction of serum albumin (Delta ALB) on postoperative day one could serve as a predictor of postoperative pulmonary complications (PPCs) after thoracoscopic anatomical resection in lung cancer patients. Methods: Patients characteristics were compared between groups of whether they experienced PPCs or not. The cutoff value of Delta ALB was examined by receiver operating characteristic curve to find out the threshold value of Delta ALB in predicting PPCs. Logistic regression analysis was conducted to identify potential risk factors for PPCs. Results: Totally 533 patients were included into analysis, and among them, 52 experienced PPCs. The Delta ALB was significant in the PPCs group than in the non-PPCs group (P<0.001), and Delta ALB was observed an independent risk factor for PPCs (OR =2.268, 95% CI: 1.153-4.460). The cutoff value of Delta ALB in predicting PPCs was 14.97%. Patients with Delta ALB >= 14.97% were more likely to have PPCs (P<0.001). Conclusions: A reduction of serum albumin with a cut-off value of 14.97% can be served as a predictor to identify patients at high risk of developing PPCs following thoracosopic anatomical lung cancer surgery.
What problem does this paper attempt to address?